Dermapharm Holding SE
XETRA:DMP

Watchlist Manager
Dermapharm Holding SE Logo
Dermapharm Holding SE
XETRA:DMP
Watchlist
Price: 37.8 EUR -0.53% Market Closed
Market Cap: 2B EUR
Have any thoughts about
Dermapharm Holding SE?
Write Note

Income Statement

Earnings Waterfall
Dermapharm Holding SE

Revenue
1.2B EUR
Cost of Revenue
-409.6m EUR
Gross Profit
749.3m EUR
Operating Expenses
-543.3m EUR
Operating Income
206.1m EUR
Other Expenses
-115.5m EUR
Net Income
90.6m EUR

Income Statement
Dermapharm Holding SE

Rotate your device to view
Income Statement
Currency: EUR
Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
475
N/A
467
-2%
487
+4%
513
+5%
546
+6%
572
+5%
599
+5%
625
+4%
661
+6%
701
+6%
730
+4%
746
+2%
760
+2%
794
+4%
814
+2%
843
+4%
887
+5%
943
+6%
962
+2%
986
+2%
1 007
+2%
1 025
+2%
1 112
+9%
1 136
+2%
1 157
+2%
1 135
-2%
1 115
-2%
1 132
+2%
1 159
+2%
Gross Profit
Cost of Revenue
(259)
(246)
(248)
(257)
(267)
(273)
(281)
(288)
(301)
(317)
(331)
(330)
(326)
(330)
(323)
(317)
(320)
(322)
(328)
(344)
(358)
(364)
(386)
(405)
(415)
(416)
(409)
(404)
(410)
Gross Profit
216
N/A
221
+3%
239
+8%
256
+7%
279
+9%
300
+7%
317
+6%
338
+6%
360
+7%
384
+7%
399
+4%
416
+4%
434
+4%
463
+7%
491
+6%
526
+7%
567
+8%
621
+9%
634
+2%
642
+1%
649
+1%
661
+2%
727
+10%
731
+1%
743
+2%
719
-3%
706
-2%
728
+3%
749
+3%
Operating Income
Operating Expenses
(124)
(131)
(141)
(157)
(175)
(185)
(212)
(227)
(248)
(262)
(268)
(289)
(302)
(321)
(342)
(342)
(333)
(325)
(329)
(365)
(380)
(377)
(457)
(483)
(520)
(518)
(542)
(537)
(543)
Selling, General & Administrative
(63)
(99)
(69)
(75)
(83)
(150)
(100)
(105)
(114)
(198)
(119)
(134)
(142)
(258)
(168)
(167)
(168)
(258)
(168)
(176)
(180)
(291)
(206)
(222)
(243)
(419)
(268)
(276)
(276)
Research & Development
0
(7)
0
0
0
(7)
0
0
0
(11)
0
0
0
(13)
0
0
0
(14)
0
0
0
(13)
0
0
0
(11)
0
0
0
Depreciation & Amortization
(15)
(16)
(18)
(22)
(24)
(24)
(37)
(41)
(47)
(46)
(49)
(49)
(48)
(44)
(51)
(51)
(51)
(45)
(57)
(84)
(85)
(51)
(104)
(99)
(106)
(86)
(109)
(99)
(99)
Other Operating Expenses
(45)
(9)
(55)
(60)
(68)
(4)
(75)
(80)
(87)
(7)
(101)
(106)
(112)
(6)
(123)
(124)
(114)
(8)
(104)
(105)
(115)
(22)
(147)
(163)
(171)
(3)
(165)
(162)
(168)
Operating Income
92
N/A
91
-2%
97
+7%
99
+2%
104
+5%
114
+10%
106
-7%
111
+5%
112
+1%
122
+9%
130
+7%
127
-3%
132
+4%
143
+8%
149
+4%
184
+24%
235
+27%
295
+26%
305
+3%
277
-9%
268
-3%
283
+6%
270
-5%
247
-8%
223
-10%
201
-10%
164
-18%
191
+16%
206
+8%
Pre-Tax Income
Interest Income Expense
(4)
(2)
(4)
(3)
(3)
(3)
(4)
(4)
(5)
(10)
(11)
(13)
(14)
(12)
(11)
(9)
(8)
(2)
(3)
(6)
(7)
(26)
(41)
(51)
(64)
(75)
(64)
(61)
(64)
Non-Reccuring Items
0
(0)
0
0
0
(6)
0
0
0
(2)
0
0
0
(4)
0
0
0
1
0
0
0
(40)
0
0
0
(16)
0
0
0
Total Other Income
0
0
0
0
0
(1)
0
0
0
(1)
0
0
0
(1)
0
0
0
(1)
0
(0)
(0)
(1)
0
0
0
(4)
0
0
0
Pre-Tax Income
88
N/A
88
0%
94
+7%
96
+2%
101
+5%
104
+3%
102
-3%
107
+5%
107
+0%
110
+3%
120
+9%
114
-5%
118
+3%
125
+6%
138
+10%
175
+28%
226
+29%
293
+29%
301
+3%
271
-10%
261
-4%
216
-17%
229
+6%
196
-14%
158
-19%
106
-33%
100
-6%
130
+30%
142
+9%
Net Income
Tax Provision
(4)
(10)
(15)
(20)
(26)
(29)
(29)
(30)
(33)
(32)
(34)
(36)
(37)
(39)
(42)
(53)
(65)
(84)
(92)
(87)
(86)
(84)
(84)
(75)
(65)
(45)
(46)
(49)
(52)
Income from Continuing Operations
84
78
79
76
75
75
73
77
74
78
85
77
81
86
95
123
162
209
210
185
175
133
145
121
93
61
55
81
89
Income to Minority Interest
0
0
0
0
0
0
0
(0)
(0)
(1)
(1)
(1)
(1)
(0)
0
1
1
1
1
1
1
2
2
2
2
2
2
2
1
Net Income (Common)
22
N/A
21
-8%
38
+86%
50
+31%
64
+28%
75
+17%
73
-3%
77
+5%
74
-4%
77
+5%
85
+10%
77
-10%
80
+4%
86
+7%
95
+11%
123
+29%
162
+32%
210
+29%
211
+1%
185
-12%
176
-5%
134
-24%
146
+9%
123
-16%
95
-23%
62
-34%
57
-9%
83
+47%
91
+9%
EPS (Diluted)
0.45
N/A
0.38
-16%
0.72
+89%
2.17
+201%
1.19
-45%
1.41
+18%
1.35
-4%
1.45
+7%
1.38
-5%
1.43
+4%
1.58
+10%
1.42
-10%
1.48
+4%
1.59
+7%
1.76
+11%
2.28
+30%
3.02
+32%
3.89
+29%
3.88
0%
3.45
-11%
3.3
-4%
2.49
-25%
2.73
+10%
2.29
-16%
1.76
-23%
1.16
-34%
1.05
-9%
1.54
+47%
1.68
+9%

See Also

Discover More